Phenotype-genotype discordance and disorders of sexual differentiation

Noninvasive Prenatal Testing (NIPT) and prenatal ultrasound can identify disorders of sexual differentiation (DSD), although discrepancies between genetic and phenotypic data can complicate diagnoses. This study explores phenotype-genotype discordance within the DSD context, focusing on methodological concerns and biological explanations. Advances in prenatal screening technologies, including cell-free DNA (cfDNA) testing and ultrasound examinations, have improved DSD detection rates. Analysis of a case featuring a 46, XY DSD due to an NR5A1 gene mutation illustrates the importance of integrating cfDNA testing with ultrasound, which enhances detection and early management. The findings underscore the necessity for a multidisciplinary approach in diagnosis and treatment planning, facilitating timely interventions that reduce psychological distress for families. The study recommends refining diagnostic algorithms that combine cfDNA testing and ultrasound to correlate genetic insights with clinical observations, thus improving patient outcomes through informed decision-making and comprehensive care strategies.